Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs

Expression of tissue inhibitor of metalloprotease 3 is reduced in ischemic but not neuropathic ulcers from patients with type 2 diabetes mellitus

(2013) R. Menghini et al.   ACTA DIABETOLOGICA

Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay

(2013) Loredana Fiorentino et al.   EMBO Molecular Medicine

Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion

(2013) Harshita Chodavarapu et al.   PLoS One

TIMP3 Overexpression in Macrophages Protects From Insulin Resistance, Adipose Inflammation, and Nonalcoholic Fatty Liver Disease in Mice

(2012) R. Menghini et al.   DIABETES

Towards microRNA-based therapeutics for diabetic nephropathy

(2012) M. L. Alvarez et al.   DIABETOLOGIA

Circulating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes

(2012) T. Gohda et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes

(2012) M. A. Niewczas et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Structural damage in diabetic nephropathy is associated with TNF-α system activity

(2011) José Manuel Fernández-Real et al.   ACTA DIABETOLOGICA

Overexpression of Tissue Inhibitor of Metalloproteinase 3 in Macrophages Reduces Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice

(2011) Viviana Casagrande et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Decreased IRS2 and TIMP3 Expression in Monocytes From Offspring of Type 2 Diabetic Patients Is Correlated With Insulin Resistance and Increased Intima-Media Thickness

(2011) M. Cardellini et al.   DIABETES

Diabetes Complications: The MicroRNA Perspective

(2011) P. Kantharidis et al.   DIABETES

Anti-microRNA-222 (Anti-miR-222) and -181B Suppress Growth of Tamoxifen-resistant Xenografts in Mouse by Targeting TIMP3 Protein and Modulating Mitogenic Signal

(2011) Yuanzhi Lu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study

(2010) Lei Kong et al.   ACTA DIABETOLOGICA

MicroRNA 217 Modulates Endothelial Cell Senescence via Silent Information Regulator 1

(2009) Rossella Menghini et al.   CIRCULATION

MicroRNAs and the kidney: coming of age

(2009) Samuel Saal et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

TIMP3 Is Reduced in Atherosclerotic Plaques From Subjects With Type 2 Diabetes and Increased by SirT1

(2009) M. Cardellini et al.   DIABETES

Increased tumor necrosis factor α-converting enzyme activity induces insulin resistance and hepatosteatosis in mice

(2009) Loredana Fiorentino et al.   HEPATOLOGY

Loss of TIMP3 Enhances Interstitial Nephritis and Fibrosis

(2009) Z. Kassiri et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN

(2009) Mitsuo Kato et al.   NATURE CELL BIOLOGY

MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators

(2008) G. Gabriely et al.   MOLECULAR AND CELLULAR BIOLOGY